Maxim Chipurik

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19

I. Efremova, V. Ivashkin, R. Maslennikov, 2021, Pulmonary Pharmacology & Therapeutics.

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)

I. Efremova, V. Ivashkin, R. Maslennikov, 2021, European Cytokine Network.